Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19
Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …
Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers
Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …
Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID‐19): a meta‐analysis of 27,492 patients
Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …
Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences
CS von Bartheld, MM Hagen… - ACS chemical …, 2020 - ACS Publications
A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …
[HTML][HTML] Key aspects in nutritional management of COVID-19 patients
A Fernández-Quintela, I Milton-Laskibar… - Journal of clinical …, 2020 - mdpi.com
This review deals with the relationship among nutrition, the immune system, and coronavirus
disease 2019 (COVID-19). The influence of nutrients and bioactive molecules present in …
disease 2019 (COVID-19). The influence of nutrients and bioactive molecules present in …
[HTML][HTML] Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms-a …
Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …
Prevalence and characteristics of taste disorders in cases of COVID-19: a meta-analysis of 29,349 patients
J Saniasiaya, MA Islam… - … –Head and Neck Surgery, 2021 - journals.sagepub.com
Objective The purpose of this meta-analysis is to assess the pooled prevalence of taste
disorders and their subtypes in patients with COVID-19. Data Sources PubMed, Scopus …
disorders and their subtypes in patients with COVID-19. Data Sources PubMed, Scopus …
Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19
CY Ho, M Salimian, J Hegert, J O'Brien, SG Choi… - JAMA …, 2022 - jamanetwork.com
Importance Loss of smell is an early and common presentation of COVID-19 infection.
Although it has been speculated that viral infection of olfactory neurons may be the culprit, it …
Although it has been speculated that viral infection of olfactory neurons may be the culprit, it …
The association of “loss of smell” to COVID-19: a systematic review and meta-analysis
Background The presence of olfactory dysfunction or “loss of smell” has been reported as an
atypical symptom in patients with coronavirus disease 2019 (COVID-19). We performed a …
atypical symptom in patients with coronavirus disease 2019 (COVID-19). We performed a …
Systematic review and meta-analysis of smell and taste disorders in COVID-19
Objective Loss of smell and taste are considered potential discriminatory symptoms
indicating triaging for coronavirus disease 2019 (COVID-19) and early case identification …
indicating triaging for coronavirus disease 2019 (COVID-19) and early case identification …